Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand

Transplantation

Volumn 64, Issue 2, 1997, Pages 329-335

  Markees, Thomas G ^a   Phillips, Nancy E ^a   Noelle, Randolph J ^b   Shultz, Leonard D ^c   Mordes, John P ^a   Greiner, Dale L ^a   Rossini, Aldo A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN TRANSPLANTATION; SPLEEN CELL; TRANSFUSION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; CHIMERA; DNA; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; LYMPH NODES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; POLYMERASE CHAIN REACTION; SKIN TRANSPLANTATION; SPLEEN;

EID: 0030860995     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00026     Document Type: Article

References (59)

1. Chen C, Nabavi N. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994; 1: 147.
2. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy [Review]. Cell 1992; 71: 1065.
3. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165: 302.
4. Thompson CB, Lindsten T, Ledbetter JA, et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 1989; 86: 1333.
5. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigenspecific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165.
6. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
7. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 1991; 173: 721.
8. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560.
9. Markees TG, Appel MC, Noelle RJ, Mordes JP, Greiner DL, Rossini AA. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation. Transplant Proc 1996; 28: 814.
10. Rossini AA, Parker DC, Phillips NE, et al. Induction of immunological tolerance to islet grafts. Cell Transplant 1996; 5: 49.
11. Laman JD, Claassen E, Noelle RJ. Functions of CD40 and its ligand, gp39 (CD40L). Crit Rev Immunol 1996; 16: 59.
12. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 1996; 14: 591.
13. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
14. Buhlmann JE, Foy TM, Aruffo A, et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995; 2: 645.
15. Davis WC, McKenzie IF, Melvold RW. A comparison of skin and heart graft rejection patterns in H-2 mutant mice. Transplantation 1980; 29: 189.
16. Markees TG, De Fazio SR, Gozzo JJ. Prolongation of adult skin allograft survival by cotransplantation of neonatal skin in antilymphocyte serum and donor bone marrow cell-treated mice. Transplantation 1990; 50: 911.
17. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992; 89: 6550.
18. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity: II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 1993; 178: 1567.
19. Schonrich G, Kalinke U, Momburg F, et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991; 65: 293.
20. b gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens. EMBO J 1983; 2: 453.
21. Siegel S. Nonparametric statistics. New York: McGraw-Hill, 1956.
22. O'Brien PC, Shampo MA. Statistical considerations for performing multiple comparisons in a single experiment: 2. Comparisons among multiple therapies. Mayo Clin Proc 1988; 63: 816.
23. Nash JR, Peters M, Bell PRF. Comparative survival of pancreatic islets, heart, kidney, and skin allografts in rats, with and without enhancement. Transplantation 1977; 24: 70.
24. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483.
25. Billingham RE, Brent L, Medawar PB. Acquired immunological tolerance. Nature 1953; 172: 603.
26. Slavin S, Strober S, Fuks Z, Kaplan HS. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 1977; 146: 34.
27. Schwadron RB, Dittmer JE, Hartnett LC. The effect of class I and class II alloantigens on skin allograft acceptance by lethally irradiated rats repopulated with syngeneic bone marrow. Transplantation 1985; 39: 558.
28. Mayumi H, Good RA. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J Exp Med 1989; 169: 213.
29. Wood ML, Gottschalk R, Monaco AP. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serumtreated, marrow-injected mice. Transplantation 1988; 46: 449.
30. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
31. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
32. Liu Y, Janeway CA Jr. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc Natl Acad Sci USA 1992; 89: 3845.
33. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992; 176: 1215.
34. Stout RD, Suttles J The many-roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996; 17: 487.
35. + T-cell responses. Immunol Today 1996; 17: 410.
36. Sprent J, Hurd M, Schaefer M, Heath W. Split tolerance in spleen chimeras. J Immunol 1995; 154: 1198.
37. Kosaka H, Sprent J. Tolerance of CDS+ T cells developing in parent→F1 chimeras prepared with supralethal irradiation: step-wise induction of tolerance in the intrathymic and extrathymic environments. J Exp Med 1993; 177: 367.
38. Wieties K, Hammer RE, Jones-Youngblood S, Forman J. Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation. Proc Natl Acad Sci USA 1990; 87: 6604.
39. Miller J, Daitch L, Rath S, Selsing E. Tissue-specific expression of allogeneic class II MHC molecules induces neither tissue rejection nor clonal inactivation of alloreactive T cells. J Immunol 1990; 144: 334.
40. Gao EK, Lo D, Sprent J. Strong T cell tolerance in parent→F1 bone marrow chimeras prepared with supralethal irradiation: evidence for clonal deletion and anergy. J Exp Med 1990; 171: 1101.
41. Morahan G, Brennan FE, Bhathal PS, Allison J, Cox KO, Miller JF. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci USA 1989; 86: 3782.
42. Sprent J, Boehmer HV, Nabholz M. Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain. J Exp Med 1975; 142: 321.
43. Webb SR, Hutchinson J, Hayden K, Sprent J. Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. J Immunol 1994; 152: 586.
44. Webb SR, Sprent J. Factors controlling the reactivity of immature and mature T cells to Mls antigens in vivo. Immunol Rev 1993; 131: 169.
45. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993; 362: 758.
46. + T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991; 123: 37.
47. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997; 3: 196.
48. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
49. Anderson CB, Brennan D, Keller C, et al. Beneficial effects of donor-specific transfusions on long-term renal allograft function. Transplant Proc 1995; 27: 991.
50. Cheigh JS, Suthanthiran M, Fotino M, et al. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. Transplantation 1991; 51: 378
51. Lau H, Reemtsma K, Hardy MA. Pancreatic islet allograft prolongation by donor-specific blood transfusions treated with ultraviolet irradiation. Science 1983; 221: 754.
52. Faustman D, Lacy P, Davie J, Hauptfeld V. Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells. Science 1982; 217: 157.
53. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25: 2643.
54. Lin H, Bolling SF, Linsley PS, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
55. Marquet RL, Heystek GA, van Leersum RH. Induction of immunologic enhancement in rats by use of antigen-antibody complexes. Transplant Proc 1977; 9: 949.
56. Pinto M, Brent L, Thomas AV. Specific unresponsiveness to skin allografts in mice: 3. Synergistic effect of tissue extracts, Bordetella pertussis, and antilymphocytic serum. Transplantation 1974; 17: 477.
57. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
58. Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 1996; 184: 955.
59. Ding L, Shevach EM. Activated B cells express CD28/B7-independent costimulatory activity. J Immunol 1996; 157: 1389.